Otolaryngology Doctors in Syracuse, NY Accepting Medicare

24 Otolaryngology doctors found. Showing 1 - 20

Dr. William Michael Harmand, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633

Dr. Alexandra Elizabeth Quimby, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7281    Fax: 315-464-7298

Anthony Joseph Mortelliti, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633

Erinn White, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3906 E Genesee St, Syracuse, NY 13214 Phone: 315-251-1093    Fax: 315-251-1571

Dr. Ryan Winters, MD Otolaryngology - Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Suny Upstate Dpt Of Otolaryngology, Syracuse, NY 13210 Phone: 315-464-4636

Adetokunbo Obayemi Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 East Adams Street, Cwb Rm 251, Syracuse, NY 13210 Phone: 201-431-5751

Haidy Adly Marzouk, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Dept. Of Otolaryngology, Syracuse, NY 13210 Phone: 315-464-5540

Amar C Suryadevara, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7279    Fax: 315-464-7282

Dr. Robert Kellman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7290

Kiranya Arnold, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7281

Richard Thomas Kelley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633

Jeffrey Alan Dorrity, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7281

John Raymond Wanamaker, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Va Medical Center, Surgical Services(112), Syracuse, NY 13210 Phone: 315-425-4400    Fax: 315-425-2639

Precha Emko, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7290

Daniel D Rabuzzi, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7 Erregger Ter, Syracuse, NY 13224 Phone: 315-446-5225

Dr. Mark Marzouk, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 Eadams Street, Syracuse, NY 13210 Phone: 315-464-4636

Mrs. Helen M Waters, AUD CCCA MS BS Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 721 E Genesee St, Fl 2, Syracuse, NY 13210 Phone: 315-476-3127    Fax: 315-476-3136

Dr. Hayes Wanamaker, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 721 E Genesee St, Fl 2nd, Syracuse, NY 13210 Phone: 315-476-3127    Fax: 315-476-3136

Charles Ira Woods Iii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633

Michael J Paciorek, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Broad Rd S 2d, Community General Hospital Pob, Syracuse, NY 13215 Phone: 315-492-5755    Fax: 315-492-5246

News Archive

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Researchers from the US and Denmark recently described a novel therapeutic option that targets the SARS-CoV-2 ribonucleic acid (RNA) using locked nucleic acid antisense oligonucleotides (LNA ASOs). They identified an LNA ASO that binds to the 5' leader sequence of SARS-CoV-2 ORF1a/b. This disrupts a highly conserved stem-loop structure with nanomolar efficacy and inhibits viral replication in host cells.

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research. Results are expected in mid-2014.

Study: Young victims of cyberbullying twice as likely to attempt suicide and enact suicidal behavior

Children and young people under 25 who are victims of cyberbullying are more than twice as likely to self-harm and enact suicidal behavior, according to a study.

Creabilis initiates CT327 Phase IIb trial in psoriasis vulgaris

Creabilis SA, a European biotechnology company specialising in the development of treatments for dermatology, inflammation and pain, today announced the start of the Phase IIb global clinical trial of its lead product CT327 in patients with psoriasis vulgaris. Recruitment is progressing well.

Read more Medical News

› Verified 4 days ago

• 1(current)
• 2